My Adrenal Life

My Adrenal Life

The My Adrenal Life Podcast provides calm, evidence-based education and supportive conversation for people living with adrenal insufficiency. Episodes explore primary (Addison’s), secondary, tertiary, and steroid-induced adrenal insufficiency, explaining the science in plain language while recognizing real patient experiences. Our goal is to reduce confusion, share reliable information, and help people navigating this complex condition feel less alone. Medical Disclaimer: This podcast is for educational purposes only and is not medical advice.

  1. Oct 25

    The Hunt for Perfect Cortisol Replacement

    In this episode of My Adrenal Life, we explore the fourth and final article in our educational series, What Happens to Your Steroid Medication After You Swallow It? Glucocorticoid replacement is essential for people living with adrenal insufficiency, but conventional oral hydrocortisone cannot fully reproduce the body’s natural cortisol rhythms. This raises an important question: Could changing when and how cortisol is delivered improve treatment outcomes? We examine the science behind circadian and ultradian cortisol rhythms, why conventional hydrocortisone creates peaks and valleys in blood concentrations, and how researchers are developing alternative delivery methods. A major focus is the difference between two modified-release hydrocortisone formulations: Plenadren, designed to provide daytime cortisol exposure, and Chronocort/Efmody, designed to more closely reproduce the natural rise in cortisol before waking. We also discuss the January 2026 CHAMPAIN clinical trial, which compared these formulations in 58 patients with primary adrenal insufficiency. Chronocort produced substantially higher early-morning cortisol concentrations, and several patient-reported fatigue and quality-of-life measures favored Chronocort. However, not every outcome improved significantly, highlighting the need for further research. The conversation also explores continuous subcutaneous hydrocortisone infusion, commonly called cortisol pump therapy. Clinical studies suggest pumps can more closely reproduce natural cortisol patterns, although research findings on improvements in symptoms and quality of life have been mixed. We examine emerging technologies, including wearable cortisol sensors and the possibility of future systems that could combine continuous cortisol monitoring with automated medication delivery. These technologies are promising research directions but are not yet established routine treatment options. Throughout the discussion, we consider why a more physiological cortisol curve does not automatically guarantee better health, why patient experiences vary, and why researchers must look beyond laboratory measurements to outcomes such as fatigue, sleep, adrenal crisis frequency, long-term health, and quality of life. Although much of the existing research focuses on primary adrenal insufficiency, we also discuss the importance of expanding studies to include secondary, tertiary, and glucocorticoid-induced adrenal insufficiency. The central takeaway: The future of glucocorticoid replacement may involve understanding not only how much cortisol a person receives, but when and how that cortisol becomes available—and whether those differences meaningfully improve everyday life. To learn more, explore the My Adrenal Life Books Authored by founder Rick Disler available on Amazon, visit www.myadrenallife.com, and join our supportive My Adrenal Life Facebook Group for education, discussion, and community.

  2. Oct 24

    Why Your Liver Rewrites Your Prescription in Adrenal Insufficiency

    Why Your Cortisol Dose Isn't Working — Part 3: Why Your Liver Rewrites Your Prescription Why can two people take the exact same dose of hydrocortisone and experience completely different results? What if the difference isn't how much medication they take, but how their bodies process it? In Part 3 of our My Adrenal Life Podcast series, What Happens to Your Steroid Medication After You Swallow It?, we explore the fascinating science of liver metabolism, medication clearance, and why the dose on your prescription bottle doesn't tell the whole story. In Parts 1 and 2, we examined how hydrocortisone enters the bloodstream. Now we follow that medication into the liver and tissues, where enzymes determine how steroid hormones are activated, deactivated, processed, and eliminated. We begin by exploring the difference between cortisol production and cortisol metabolism. Even when someone cannot produce enough cortisol naturally, their body continues processing the replacement medication they take. We discuss two important enzymes, 11β-HSD1 and 11β-HSD2, which regulate the conversion between active cortisol and inactive cortisone. These processes help determine cortisol activity within individual tissues, meaning circulating hormone concentrations don't always tell the complete story. We also examine CYP3A4, a liver enzyme involved in metabolizing many medications, including certain glucocorticoids. In this episode, we explore: Fast versus slow metabolism: Why some people may process glucocorticoids differently and why symptoms alone cannot establish rapid clearance. Medication interactions: How drugs such as rifampin and certain seizure medications can accelerate steroid metabolism, while other medications can slow clearance and increase glucocorticoid exposure. Supplements matter too: Why products such as St. John's wort can interact with medication-processing enzymes. The difference between steroids: Why hydrocortisone, prednisone, prednisolone, and dexamethasone have different activation pathways, durations, and metabolic characteristics. Liver disease and cortisol: How impaired liver function and changes in cortisol-binding proteins can complicate medication exposure and laboratory interpretation. Genetics and individual differences: Why someone's metabolic response involves more than a single gene. Emerging research: How blood testing and urinary steroid metabolomics may help researchers better understand individual hormone-processing pathways. We also discuss a published case involving a patient with primary adrenal insufficiency whose previously stable hydrocortisone replacement became inadequate after starting rifampin. The case illustrates an important reality: a medication interaction can change glucocorticoid exposure even when someone hasn't missed a single dose. On the opposite side, medications that inhibit steroid metabolism can increase exposure to certain glucocorticoids, potentially contributing to excessive steroid effects and suppression of the body's natural cortisol production. These interactions make it especially important for people with primary, secondary, tertiary, or steroid-induced adrenal insufficiency to review new medications and supplements with their healthcare team. Throughout the conversation, we emphasize that feeling like hydrocortisone wears off quickly doesn't automatically mean you're a fast metabolizer. Absorption, tissue sensitivity, other medications, and individual physiology may all contribute. The takeaway? Your prescription tells you how much medication you take. Your body determines how that medication is processed. Understanding both matters. To learn more, explore the My Adrenal Life Books Authored by founder Rick Disler available on Amazon, visit www.myadrenallife.com, and join our supportive My Adrenal Life Facebook Group for education, discussion, and community.

  3. Oct 23

    THE GUT–MEDICATION CONNECTION: WHAT IF ABSORPTION IS THE PROBLEM?

    Why Your Cortisol Dose Isn't Working — Part 2: Is Your Body Actually Absorbing Your Hydrocortisone? You take your hydrocortisone, wait for it to start working, and sometimes nothing happens. Or the relief comes much later than expected. Why? For people living with adrenal insufficiency, knowing that medication was swallowed isn't quite the same as knowing how quickly—or how much of it—reached the bloodstream. In Part 2 of our My Adrenal Life podcast series, What Happens to Your Steroid Medication After You Swallow It?, we explore the science of hydrocortisone absorption and why digestive health can influence how replacement medication behaves. Research suggests that oral hydrocortisone is generally absorbed very efficiently, with one controlled study reporting approximately 96% bioavailability. But that average doesn't guarantee identical absorption or timing for every person. We explain the journey of a hydrocortisone tablet through the digestive system, from breaking apart and dissolving to passing through the intestinal lining and entering circulation. In this episode, we explore: Delayed absorption versus reduced absorption: Why medication arriving late isn't necessarily the same as medication being lost. Food and medication timing: How meals may change the timing and peak of hydrocortisone absorption, depending on the formulation. Gastroparesis: Why delayed stomach emptying raises important questions about medication delivery, even though direct hydrocortisone research remains limited. Crohn's disease and celiac disease: How intestinal inflammation, damaged intestinal lining, and disease location may affect absorption—and where the evidence is still incomplete. Vomiting and diarrhea: Why gastrointestinal illness creates special concerns for people who depend on oral glucocorticoid replacement. Bariatric surgery: What a small study found about hydrocortisone exposure after gastric bypass and sleeve gastrectomy, including some surprising results. Understanding cortisol curves: What researchers mean by Tmax (time to peak), Cmax (peak concentration), and AUC (overall medication exposure). We also discuss an important distinction: feeling unwell does not automatically mean your medication isn't being absorbed. Sometimes the problem may involve delayed absorption. Sometimes illness increases the body's cortisol requirements. Other possibilities include medication clearance, dehydration, or symptoms caused by another medical condition. Understanding these differences can help patients describe their experiences more clearly and have more informed conversations with their endocrinologists. We also address the serious safety implications of persistent vomiting or severe diarrhea. When oral glucocorticoids cannot be reliably retained or absorbed, established emergency protocols and prompt medical care become essential. Throughout the conversation, we examine what published research supports, what remains uncertain, and why conditions such as gastroparesis, active celiac disease, and long-term changes following bariatric surgery deserve further study. The central takeaway? Hydrocortisone is generally well absorbed, but how quickly it reaches the bloodstream—and how consistently that happens—can matter. Digestive symptoms alone cannot tell us exactly what is happening to a dose. This discussion is relevant to people with primary, secondary, tertiary, and glucocorticoid-induced adrenal insufficiency who depend on oral replacement medication. Coming in Part 3: Once hydrocortisone reaches the bloodstream, what happens next? We'll explore liver metabolism, medication clearance, interactions with other drugs, and why some people may process glucocorticoids faster or slower than others. To learn more, explore the My Adrenal Life Books Authored by founder Rick Disler available on Amazon, visit www.myadrenallife.com, and join our supportive My Adrenal Life Facebook Group for education, discussion, and community.

  4. Oct 22

    Why Your Cortisol Dose Isn't Working

    Why Your Cortisol Dose Isn't Working — Part 1: What Happens After You Swallow Hydrocortisone? Why can two people take the exact same dose of hydrocortisone and have completely different experiences? One person feels relatively stable throughout the morning. Another experiences a brief improvement followed by overwhelming fatigue, brain fog, or a sudden crash. Both may be following their prescribed treatment plan. So why does the same medication behave so differently? In this episode of the My Adrenal Life Podcast, we explore the science behind how the body processes hydrocortisone and why the dose printed on your prescription bottle doesn't necessarily tell the whole story about your body's cortisol exposure. Research discussed in this episode found that cortisol exposure can vary more than tenfold between individuals, even when researchers account for body weight. Another study demonstrated substantial differences in cortisol concentrations following intravenous hydrocortisone administration, showing that the digestive system is only one part of the equation. We break down the four stages of pharmacokinetics, known as ADME: Absorption, Distribution, Metabolism, and Excretion. You'll discover why the speed of absorption, cortisol-binding proteins, liver metabolism, medication clearance, and tissue-level hormone activity can all influence how hydrocortisone behaves. We also explore some of the questions frequently raised in the adrenal insufficiency community: Why does hydrocortisone seem to wear off sooner for some people? Does crashing between doses necessarily mean you're a fast metabolizer? What's the difference between total cortisol and free cortisol? How can estrogen therapy and cortisol-binding globulin influence cortisol measurements? Why doesn't adjusting medication solely by body weight eliminate individual differences? How do natural cortisol rhythms differ from the peaks and declines produced by oral medication? Why can't one cortisol blood test or symptom pattern tell the entire story? This conversation applies to people living with primary adrenal insufficiency (Addison's disease), secondary adrenal insufficiency, tertiary adrenal insufficiency, and glucocorticoid-induced adrenal insufficiency. We also discuss the difference between pharmacokinetics—what your body does to medication—and pharmacodynamics—how that medication affects your tissues. Perhaps one of the most important takeaways is that feeling worse between doses does not automatically establish that you need more medication. Absorption, timing, clearance, other health conditions, and individual responses may all contribute. Understanding those differences can help patients have more informed conversations with their endocrinologists without risking unnecessary overreplacement. We look at where the research stands today, why scientists still cannot identify one ideal cortisol exposure pattern for every patient, and how newer hydrocortisone delivery approaches may help address some limitations of conventional replacement therapy. The central message? Two people taking 20 mg of hydrocortisone may experience very different patterns of cortisol exposure. Comparing prescription doses alone doesn't tell us how their bodies are responding. This episode is about understanding the science behind those differences, recognizing what research has established, and identifying the questions that still need answers. Coming in Part 2: We take a closer look at hydrocortisone absorption and what happens when gastrointestinal conditions such as celiac disease, Crohn's disease, or changes in stomach emptying interfere with the journey from tablet to bloodstream. To learn more, explore the My Adrenal Life Books Authored by founder Rick Disler available on Amazon, visit www.myadrenallife.com, and join our supportive My Adrenal Life Facebook Group for education, discussion, and community.

  5. Oct 18

    ACTH Stimulation Testing: Why 18 Is Not a Universal Pass/Fail Number

    ACTH Stimulation Testing: Why 18 Is Not a Universal Pass/Fail Number What if the cortisol number you’ve been told determines whether your adrenal glands are functioning properly isn’t actually the right number for the test your laboratory used? For decades, people undergoing ACTH stimulation testing have heard the same rule: Your cortisol needs to reach 18 µg/dL to pass. But advances in laboratory testing have revealed that interpreting adrenal function is far more complicated than comparing a result to one universal cutoff. In this episode of the My Adrenal Life Podcast, we explore new research challenging the traditional 18 µg/dL threshold and explain why the laboratory assay, testing protocol, sample timing, medication history, and type of adrenal insufficiency all influence what a cortisol result actually means. We begin with an October 2026 systematic review examining the Roche Elecsys Cortisol II assay. After analyzing six studies involving 430 adults and children, researchers proposed a peak stimulated cortisol cutoff of approximately 14.7 µg/dL for the standard 250-microgram ACTH stimulation test. That’s considerably lower than the traditional 18 µg/dL threshold. But does that mean someone who previously failed an ACTH stimulation test might now pass? Possibly—but only when the laboratory method, testing protocol, and clinical circumstances support that interpretation. We explain why newer cortisol assays often report lower concentrations than older testing methods, even when the patient’s underlying adrenal function hasn’t changed. The biology may be the same, but the measuring stick is different. We also break down what an ACTH stimulation test actually measures: the adrenal glands’ ability to produce cortisol when stimulated by synthetic ACTH. This distinction is especially important when comparing primary adrenal insufficiency with secondary, tertiary, and steroid-induced adrenal insufficiency, where impaired pituitary signaling, adrenal responsiveness, and the timing of HPA-axis suppression can complicate results. Other important questions we explore include: Why do 30-minute and 60-minute cortisol results matter? Cortisol may peak at different times, and a cutoff must match the protocol used.Is a morning cortisol test the same as an ACTH stimulation test? No. These tests answer different questions, particularly when evaluating recovery after glucocorticoid exposure.Can estrogen and cortisol-binding proteins change test results? Yes. Changes in binding proteins can influence total measured cortisol without producing equivalent changes in free cortisol.How do previous steroid treatments affect testing? Oral medications, injections, inhaled glucocorticoids, and other exposures can influence HPA-axis function and, in some circumstances, laboratory measurements.What does a passing result actually mean? A reassuring stimulated cortisol result does not necessarily establish that every aspect of the body’s natural stress response has recovered.We also discuss the 2024 Endocrine Society and European Society of Endocrinology guidance on evaluating recovery from glucocorticoid-induced adrenal insufficiency, including why morning cortisol is interpreted differently from stimulated cortisol. Perhaps most importantly, we explore what patients should ask their endocrinologists when reviewing results—especially when those results may influence decisions about glucocorticoid replacement, HPA-axis recovery, or ongoing sick-day and emergency precautions. The new 14.7 µg/dL proposal does not mean everyone below 18 is suddenly normal. And it does not mean everyone above 14.7 has a fully functioning cortisol stress response. To learn more, explore the My Adrenal Life Books Authored by founder Rick Disler available on Amazon, visit www.myadrenallife.com, and join our supportive My Adrenal Life Facebook Group for education, discussion, and community.

  6. Oct 16

    Waking Up at 3 A.M.? Why It Isn’t Always Low Cortisol

    Waking Up at 3 A.M.? Why It Isn’t Always Low Cortisol Do you find yourself waking up at 3 a.m., sometimes with a racing heart, sweating, or feeling strangely alert—even though you were exhausted when you went to bed? If you live with adrenal insufficiency, you may immediately wonder: Is my cortisol dropping too low? In this episode of the My Adrenal Life Podcast, we explore the fascinating relationship between cortisol, sleep, and the body’s internal clock—and challenge one of the most common assumptions in the adrenal insufficiency community: Waking up at 3 a.m. does not automatically mean your cortisol is low. We begin by examining what cortisol is actually supposed to do overnight. In a healthy body, cortisol naturally declines during the evening, remains relatively low during the early part of the night, and begins rising again as morning approaches. We explain the difference between the circadian rhythm, which regulates cortisol across approximately 24 hours, and the ultradian rhythm, which produces smaller cortisol pulses throughout the day and night. For people living with primary, secondary, tertiary, or steroid-induced adrenal insufficiency, these natural rhythms may be disrupted. Traditional glucocorticoid replacement does not perfectly reproduce the body’s normal hormone patterns, raising important questions about nighttime cortisol availability, medication timing, and sleep quality. But cortisol is only one part of the story. We take a deeper look at what actually happens inside the sleeping brain, including the transition between deep sleep and REM sleep, changes in autonomic nervous system activity, and why awakenings may become more noticeable during the second half of the night. One particularly important discussion centers on hydrocortisone wearing off overnight. While circulating cortisol from immediate-release medication declines after a dose, that does not automatically establish that a nighttime awakening is caused by clinically significant cortisol deficiency—or that additional nighttime glucocorticoid replacement is appropriate. We also examine why a single nighttime cortisol measurement or commercial at-home cortisol test may not provide the answers people expect. Throughout the episode, we distinguish ordinary sleep disruption from symptoms that may indicate inadequate cortisol availability or a developing adrenal emergency. Recognizing other possible causes of nighttime waking should never mean overlooking serious symptoms or established sick-day and emergency protocols. Finally, we explore where adrenal insufficiency sleep research needs to go next, including overnight hormone monitoring, objective sleep studies, cortisol delivery systems, autonomic function, menopause-related sleep changes, and recovery of the HPA axis after steroid exposure. The bigger message is that your body is more than one hormone. Cortisol may contribute to disrupted sleep, but so can breathing problems, pain, reproductive hormones, thyroid function, blood glucose, and the brain’s normal sleep cycles. Waking at 3 a.m. is information about your sleep. It is not, by itself, proof of cortisol deficiency. Instead of asking only, “Why is my cortisol dropping at 3 a.m.?” perhaps the more useful question is: “What is actually interrupting my sleep?” To learn more, explore the My Adrenal Life Books Authored by founder Rick Disler available on Amazon, visit www.myadrenallife.com, and join our supportive My Adrenal Life Facebook Group for education, discussion, and community.

  7. Oct 14

    Beyond the Daily Pill: Reimagining Cortisol Replacement

    Beyond the Daily Pill: Reimagining Cortisol Replacement What if replacing cortisol isn't the same as recreating the way cortisol actually works in the human body? In this episode of the My Adrenal Life Podcast, we explore one of the most fascinating questions shaping the future of adrenal insufficiency care: Can we move beyond simply replacing cortisol toward treatments that more closely reproduce the body's natural hormone rhythms? For people living with adrenal insufficiency, glucocorticoid replacement is essential and life-saving. But even when medications are taken exactly as prescribed, conventional treatment cannot fully reproduce the complex timing, fluctuations, and continuous adjustments of natural cortisol production. We begin by exploring the science of cortisol's two overlapping rhythms: the circadian rhythm, which helps regulate cortisol throughout the day and night, and the ultradian rhythm, which produces smaller hormonal pulses approximately every 60–120 minutes. These rhythms influence far more than when someone feels awake or tired. Cortisol signaling affects metabolism, immune regulation, cellular activity, and how genes respond to hormonal messages. Research suggests that cells can respond differently to pulsatile versus continuous glucocorticoid exposure—even when the total amount of hormone is similar. We then examine why traditional oral hydrocortisone creates a different pattern. Rather than continuously adjusting to the body's needs, each dose produces a rise and subsequent decline in circulating cortisol. Two people taking the same daily dose may experience very different patterns of hormone exposure because of differences in absorption, metabolism, medication timing, and individual physiology. That raises an important question for patients who experience predictable fatigue, weakness, brain fog, or changes in functioning between doses: Could the timing of cortisol exposure be part of the problem? We discuss why these patterns deserve attention, while also recognizing that symptoms alone cannot determine whether someone is receiving too much or too little cortisol. The conversation then turns toward emerging treatment approaches. Modified-release hydrocortisone formulations are designed to better approximate certain features of natural cortisol secretion, including the early-morning rise or more sustained daytime coverage. Continuous subcutaneous hydrocortisone infusion, sometimes called cortisol pump therapy, offers another approach by delivering medication through a programmable device rather than relying entirely on oral tablets. We also explore research into pulsatile cortisol delivery, including the PULSES study, which investigates whether recreating the body's natural hormonal pulses could influence sleep, fatigue, emotional processing, and other aspects of health. These developments are exciting, but important questions remain. Producing a more natural-looking cortisol pattern does not automatically guarantee better long-term health or quality of life. Researchers still need to determine which approaches provide meaningful benefits, for whom, and with what risks. Finally, we discuss how patients can bring these questions into their endocrinology appointments by tracking medication timing, recurring symptoms, and changes in daily functioning—creating a clearer picture for conversations about treatment. Whether you're living with primary, secondary, tertiary, or steroid-induced adrenal insufficiency, this discussion offers a deeper understanding of why the total daily dose is only one part of the cortisol replacement story. To learn more, explore the My Adrenal Life Books Authored by founder Rick Disler available on Amazon, visit www.myadrenallife.com, and join our supportive My Adrenal Life Facebook Group for education, discussion, and community.

  8. Oct 13

    Thyroid & Cortisol: Same Symptoms. Different Rules.

    Thyroid & Cortisol: Same Symptoms. Different Rules. Fatigue, brain fog, weight changes, muscle weakness, temperature intolerance, heart-rate changes, and poor sleep. Are these symptoms coming from your thyroid, your adrenal insufficiency, or both? In this episode of the My Adrenal Life Podcast, we explore the complicated relationship between thyroid hormones and cortisol—and why understanding how these two endocrine systems interact can make an enormous difference in recognizing symptoms, interpreting laboratory results, and managing treatment safely. The thyroid and adrenal systems influence many of the same functions, including metabolism, cardiovascular health, energy, glucose regulation, and physical stamina. But similar symptoms do not mean the same underlying problem—or the same treatment approach. We begin with one of the most important principles in endocrinology: When both adrenal insufficiency and hypothyroidism are suspected, adequate cortisol availability must be addressed before thyroid hormone treatment is initiated or substantially increased. Thyroid hormone can increase cortisol metabolism, potentially exposing an already limited adrenal reserve and, in some circumstances, precipitating adrenal crisis. We also explain why thyroid testing follows different rules depending on where the problem originates. In primary hypothyroidism, TSH is generally an important guide. But in central hypothyroidism caused by pituitary or hypothalamic dysfunction, a normal or low TSH can be misleading, making free T4 particularly important. The conversation goes even deeper into how cortisol and glucocorticoid medications can influence thyroid laboratory results. Higher glucocorticoid exposure may suppress TSH and reduce the conversion of T4 to T3, while cortisol deficiency can sometimes raise TSH. Significant illness, hospitalization, and stress dosing can further complicate interpretation. We also explore two important connections: autoimmune Addison’s disease and autoimmune thyroid disease can occur together, while pituitary disorders can simultaneously disrupt ACTH and TSH signaling, leading to secondary adrenal insufficiency and central hypothyroidism. Other topics include how thyroid and adrenal disorders can affect weight, heart rate, blood pressure, sodium, and blood glucose; why low T3 doesn’t automatically mean someone needs T3 medication; and how supplements such as biotin, iodine, ashwagandha, and licorice may complicate endocrine management or laboratory interpretation. Perhaps one of the most practical distinctions involves illness. Cortisol replacement has sick-day and emergency protocols. Thyroid hormone generally does not follow those same rules. Vomiting that prevents someone from retaining oral glucocorticoid medication can become an emergency, while missing a single levothyroxine tablet usually carries a very different level of urgency. Throughout this discussion, we emphasize why persistent symptoms deserve thoughtful evaluation rather than automatically increasing thyroid medication or glucocorticoid replacement. Medication timing, absorption, other medical conditions, and the broader symptom pattern all matter. Whether you’re living with primary, secondary, tertiary, or steroid-induced adrenal insufficiency—and whether your thyroid condition is primary or central—understanding these differences can help you have more informed conversations with your healthcare team. The central message: Don’t treat the symptom list. Understand the physiology. Because when thyroid hormones and cortisol produce overlapping symptoms, the most useful question isn’t simply, “Which medication should I change?” It’s “Which system is actually asking for help?” To learn more, explore the My Adrenal Life Books Authored by founder Rick Disler available on Amazon, visit www.myadrenallife.com, and join our supportive My Adrenal Life Facebook Group for education, discussion, and community.

Ratings & Reviews

5
out of 5
7 Ratings

About

The My Adrenal Life Podcast provides calm, evidence-based education and supportive conversation for people living with adrenal insufficiency. Episodes explore primary (Addison’s), secondary, tertiary, and steroid-induced adrenal insufficiency, explaining the science in plain language while recognizing real patient experiences. Our goal is to reduce confusion, share reliable information, and help people navigating this complex condition feel less alone. Medical Disclaimer: This podcast is for educational purposes only and is not medical advice.

You Might Also Like